4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-17-026295
$CPIXCIK 0001087294operating
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:52 PM ET
Size
6.3 KB
Accession
0001209191-17-026295
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2017-04-07$6.45/sh−653$4,212→ 14,647 total - Award
Common Stock
2017-04-07$6.45/sh+2,500$16,125→ 15,300 total
Footnotes (2)
- [F1]Restricted stock award will vest 100% on March 17, 2021.
- [F2]This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 2,000 shares during March 2017.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:52 PM ET
- Size
- 6.3 KB